Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OrthoDerm
- Development stage
- Phase 2
- Lead developer
- Cure Therapeutics
- Modality
- Small Molecules
- Administration
- Transdermal
01
Overview
OrthoDerm is a low-dose nitroglycerin transdermal patch specifically developed for the treatment of chronic lateral epicondylitis (tennis elbow). Developed by Cure Therapeutics, it utilizes a patch delivery system to provide a sustained, localized release of nitroglycerin to the affected tendon site. Nitroglycerin acts as an exogenous source of nitric oxide (NO), a molecule essential for tendon repair. In tendinopathy, nitric oxide is thought to stimulate collagen synthesis by fibroblasts and enhance local microcirculation in the hypovascular region of the tendon. By modulating these biological pathways, OrthoDerm aims to accelerate the healing process, reduce pain, and restore functional mobility in patients with chronic tendon injuries.
- Brand names
- OrthoDerm
- Other names
- OrthoDerm Transdermal Nitroglycerin PatchNitroglycerin transdermal patchGlyceryl trinitrate patchGTN patch
Beyond the preview
Go deeper on OrthoDerm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OrthoDerm.